WA
PFE icon

WPG Advisers’s Pfizer PFE Stock Holding History

WPG Advisers’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$79.3K Sell
2,824
-4,250
-60% -$113K 0.06% 182
2025
Q4 		$176K Buy
7,074
+3,022
+75% +$76.2K 0.13% 101
2025
Q3 		$103K Buy
4,052
+2,191
+118% +$54.1K 0.08% 152
2025
Q2 		$45.1K Buy
1,861
+498
+37% +$11.6K 0.04% 297
2025
Q1 		$34.5K Buy
1,363
+370
+37% +$9.68K 0.03% 352
2024
Q4 		$26.3K Buy
+993
New +$26.9K 0.02% 402

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

WPG Advisers's PFE Position: Q1 2026 in Review

WPG Advisers reduced its Pfizer (PFE) stake by 60% in Q1 2026, selling an estimated $113K and leaving 2,824 shares worth $79.3K. The position accounts for 0.06% of the portfolio, ranked #182.

WPG Advisers first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. The position peaked at $176K in Q4 2025. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • WPG Advisers held 2,824 shares of Pfizer worth $79.3K as of Q1 2026.
  • WPG Advisers sold 4,250 Pfizer shares in Q1 2026, an estimated $113K.
  • Pfizer made up 0.06% of WPG Advisers's portfolio in Q1 2026, its #182 holding.
  • WPG Advisers first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • WPG Advisers's Pfizer position peaked at $176K in Q4 2025.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on WPG Advisers's 13F filing for Q1 2026, filed 30 Apr 2026.